Cargando…
Reply to Sun et al.: circGASP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
Autores principales: | Sun, Yuan-Yuan, Wang, Lan, Liu, Jin-Ming, Yuan, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787256/ https://www.ncbi.nlm.nih.gov/pubmed/34739352 http://dx.doi.org/10.1164/rccm.202108-1905LE |
Ejemplares similares
-
Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021) -
circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
por: Sun, Xishi, et al.
Publicado: (2021) -
Reply to Kobayashi et al.: Too Premature to Deny the Potential of Thrombomodulin Alfa in Idiopathic Pulmonary Fibrosis
por: Kondoh, Yasuhiro, et al.
Publicado: (2020) -
Reply to Chen et al.: BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Provencher, Steeve, et al.
Publicado: (2020) -
Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Badagliacca, Roberto, et al.
Publicado: (2021)